We demonstrated that human MSCs secreted high levels of CCR5 ligands (i.e., CCL3, CCL4, and CCL5), and that MSCs promoted CRC tumor growth in vivo via CCR5 signaling. The gene discussed is CCL3; the disease is neoplasm.